TheEdgeResearch
Home / Stocks / FTHWF

Field Trip Health & Wellness Ltd. (FTHWF)

OTC Healthcare Biotechnology
$0.04 ▲ +0.00%
Market Cap
$3.7M
Sector
Healthcare
Industry
Biotechnology
Beta
0.00
52-Wk Range
0.0177-0.5
CEO
Ronan Levy
Country
CA
Currency
USD

Field Trip Health & Wellness Ltd. operates in the Biotechnology industry of the Healthcare sector, headquartered in Toronto, ON, CA. The stock last traded at $0.04, up 0.00% on the session, giving a market capitalisation of $3.7M. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-0.01
Price / Sales
0.00
Price / Book
0.03
EV / EBITDA
1.08
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.16
Current ratio
3.52
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
—
IPO date
2022-08-18
Headquarters
Toronto, ON, CA
About Field Trip Health & Wellness Ltd.

Field Trip Health Ltd. is a company based in Toronto, Canada, that specializes in developing and delivering psychedelic-assisted therapies across North America. The firm manages Field Trip Health Centres, which administer psychedelic treatments, and offers Field Trip Digital applications. Additionally, through its Field Trip Discovery division, it conducts research to create innovative psychedelic molecules. The company provides ketamine-assisted therapy for various conditions, including depression, anxiety, and addiction. Field Trip Health Ltd. was founded in 2008.

Comparable companies

Field Trip Health & Wellness Ltd. is most often compared with the following Healthcare names:

AWKNFBRRGFDOGPHERTFIPCIFNSTGQOCTHFPSCBFSEPSFVANI
More research on FTHWF
FTHWF technical analysis FTHWF TheEdge Score Compare against peers
Open full interactive analysis & DCF →